These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Diagnosis of medullary carcinoma of the thyroid (MCT) by calcitonin assay using monoclonal antibodies: criteria for the pentagastrin stimulation test in hereditary MCT. Guilloteau D; Perdrisot R; Calmettes C; Baulieu JL; Lecomte P; Kaphan G; Milhaud G; Besnard JC; Jallet P; Bigorgne JC J Clin Endocrinol Metab; 1990 Oct; 71(4):1064-7. PubMed ID: 2401708 [TBL] [Abstract][Full Text] [Related]
3. Pentagastrin stimulation test and early diagnosis of medullary thyroid carcinoma using an immunoradiometric assay of calcitonin: comparison with genetic screening in hereditary medullary thyroid carcinoma. Barbot N; Calmettes C; Schuffenecker I; Saint-André JP; Franc B; Rohmer V; Jallet P; Bigorgne JC J Clin Endocrinol Metab; 1994 Jan; 78(1):114-20. PubMed ID: 7904611 [TBL] [Abstract][Full Text] [Related]
4. Thyroid venous catheterization in the early diagnosis of familial medullary thyroid carcinoma. Wells SA; Baylin SB; Johnsrude IS; Harrington DP; Mendelsohn G; Ontjes DJ; Cooper CW Ann Surg; 1982 Nov; 196(5):505-11. PubMed ID: 7125737 [TBL] [Abstract][Full Text] [Related]
5. Results of the calcitonin stimulation test in normal volunteers compared with genetically unaffected members of MEN 2A and familial medullary thyroid carcinoma families. Wion-Barbot N; Schuffenecker I; Niccoli P; Conte-Devolx B; Lecomte P; Houdent C; Bigorgne JC; Modigliani E Ann Endocrinol (Paris); 1997; 58(4):302-8. PubMed ID: 9436479 [TBL] [Abstract][Full Text] [Related]
6. Predictive value of pentagastrin test for preoperative differential diagnosis between C-cell hyperplasia and medullary thyroid carcinoma in patients with moderately elevated basal calcitonin levels. Milone F; Ramundo V; Chiofalo MG; Severino R; Paciolla I; Pezzullo L; Lombardi G; Colao A; Faggiano A Clin Endocrinol (Oxf); 2010 Jul; 73(1):85-8. PubMed ID: 20039894 [TBL] [Abstract][Full Text] [Related]
8. Is basal ultrasensitive measurement of calcitonin capable of substituting for the pentagastrin-stimulation test? Pina G; Dubois S; Murat A; Berger N; Niccoli P; Peix JL; Cohen R; Guillausseau C; Charrie A; Chabre O; Cornu C; Borson-Chazot F; Rohmer V; Clin Endocrinol (Oxf); 2013 Mar; 78(3):358-64. PubMed ID: 22913268 [TBL] [Abstract][Full Text] [Related]
9. Determination of serum calcitonin by immunometric two-site assays in normal subjects and patients with medullary thyroid carcinoma. Zink A; Blind E; Raue F Eur J Clin Chem Clin Biochem; 1992 Dec; 30(12):831-5. PubMed ID: 1489858 [TBL] [Abstract][Full Text] [Related]
10. Routine measurement of serum calcitonin is useful for early detection of medullary thyroid carcinoma in patients with nodular thyroid diseases. Hahm JR; Lee MS; Min YK; Lee MK; Kim KW; Nam SJ; Yang JH; Chung JH Thyroid; 2001 Jan; 11(1):73-80. PubMed ID: 11272100 [TBL] [Abstract][Full Text] [Related]
11. Validation, role in perioperative assessment, and clinical applications of an immunoradiometric assay for human calcitonin. Wimalawansa SJ; Bailey F Peptides; 1995; 16(2):307-12. PubMed ID: 7784260 [TBL] [Abstract][Full Text] [Related]
12. Comparison of two provocative tests for calcitonin in medullary thyroid carcinoma: omeprazole vs pentagastrin. Vitale G; Ciccarelli A; Caraglia M; Galderisi M; Rossi R; Del Prete S; Abbruzzese A; Lupoli G Clin Chem; 2002 Sep; 48(9):1505-10. PubMed ID: 12194927 [TBL] [Abstract][Full Text] [Related]
13. Medullary carcinoma of the thyroid. (Clinical and endocrinological features of six cases). degli Uberti EC; Trasforini G; Bagni B; Liboni A; Pansini GC; Altavilla G Ric Clin Lab; 1981; 11(2):171-8. PubMed ID: 7268276 [TBL] [Abstract][Full Text] [Related]
14. Clinical performance of an extraction calcitonin radioimmunoassay. Kao PC; Gharib H Mayo Clin Proc; 1993 Dec; 68(12):1165-70. PubMed ID: 8246617 [TBL] [Abstract][Full Text] [Related]
15. Ghrelin in human medullary thyroid carcinomas. Morpurgo PS; Cappiello V; Verga U; Vicentini L; Vaghi I; Lauri E; Nebuloni M; Beck-Peccoz P; Spada A Clin Endocrinol (Oxf); 2005 Oct; 63(4):437-41. PubMed ID: 16181236 [TBL] [Abstract][Full Text] [Related]
16. Calcitonin screening and pentagastrin testing: predictive value for the diagnosis of medullary carcinoma in nodular thyroid disease. Herrmann BL; Schmid KW; Goerges R; Kemen M; Mann K Eur J Endocrinol; 2010 Jun; 162(6):1141-5. PubMed ID: 20332126 [TBL] [Abstract][Full Text] [Related]
17. Screening for medullary carcinoma of the thyroid in families with Sipple's syndrome: evaluation of new stimulation tests. Telenius-Berg M; Almqvist S; Berg B; Hedner P; Ingemansson S; Tibblin S; Wasthed B Eur J Clin Invest; 1977 Feb; 7(1):7-16. PubMed ID: 402280 [TBL] [Abstract][Full Text] [Related]
18. Omeprazole: calcitonin stimulation test for the diagnosis follow-up and family screening in medullary thyroid carcinoma. Erdoğan MF; Güllü S; Başkal N; Uysal AR; Kamel N; Erdoğan G J Clin Endocrinol Metab; 1997 Mar; 82(3):897-9. PubMed ID: 9062503 [TBL] [Abstract][Full Text] [Related]
19. Basal and stimulated calcitonin and procalcitonin by various assays in patients with and without medullary thyroid cancer. Kratzsch J; Petzold A; Raue F; Reinhardt W; Bröcker-Preuss M; Görges R; Mann K; Karges W; Morgenthaler N; Luster M; Reiners C; Thiery J; Dralle H; Fuhrer D Clin Chem; 2011 Mar; 57(3):467-74. PubMed ID: 21159900 [TBL] [Abstract][Full Text] [Related]
20. Calcitonin and PDN-21 as tumour markers in MEN-2 family screening for medullary thyroid carcinoma. Schifter S Eur J Cancer; 1992; 28(2-3):341-5. PubMed ID: 1350454 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]